文献速递慢性静脉疾病

溃疡下超声引导泡沫硬化治疗静脉性腿溃疡:FINNULCER随机对照试验结果

Sub-ulcer Ultrasound Guided Foam Sclerotherapy for Venous Leg Ulcers: Results of the FINNULCER Randomised Controlled Trial.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-07-02

FINNULCER多中心非盲平行组随机对照试验在芬兰四家血管外科单位纳入73例静脉性腿溃疡患者,比较在常规治疗基础上加用溃疡下超声引导泡沫硬化治疗(UGFS)与单纯常规治疗的疗效。

要点

  • 加用溃疡下UGFS可缩短静脉性腿溃疡愈合时间,中位愈合时间由91天降至55天。
  • 两组总体并发症率相似,生活质量改善程度亦相似。

核心结论

  • 在常规治疗基础上加用溃疡下UGFS可缩短静脉性腿溃疡愈合时间,且不增加总体并发症率。
  • 结果提示治疗溃疡下静脉丛可能是静脉性腿溃疡管理的有益补充。
  • 但需注意实际样本量小于原计划,结果解释应谨慎。

研究设计与样本

  • 多中心、非盲、平行组随机对照试验(FINNULCER)。
  • 从芬兰四家血管外科单位招募静脉性腿溃疡患者。
  • 共随机73例,研究组35例接受立即溃疡下UGFS加常规治疗,对照组38例仅接受常规治疗。
  • 常规治疗包括对反流性主干静脉行计划性腔内热消融、对属支行UGFS、压力治疗(推荐2级23–32 mmHg大腿长压力袜)及局部溃疡护理。
  • 主要结局为1年随访内溃疡愈合时间。

主要发现

  • 随访期间研究组所有溃疡均愈合,对照组38例中4例未愈合。
  • 研究组中位溃疡愈合时间为55天(95%CI 42–68天),对照组为91天(95%CI 73–109天)。
  • 两组生活质量改善相似。
  • 两组总体并发症率相似。

关键数值与推荐

  • 推荐压力治疗为2级(23–32 mmHg)大腿长压力袜。
  • 主要结局为1年内溃疡愈合时间。
  • 研究组中位愈合时间55天(95%CI 42–68天),对照组91天(95%CI 73–109天)。

临床怎么用

  • 对于静脉性腿溃疡患者,在常规治疗(包括计划性热消融、属支UGFS、压力治疗和局部护理)基础上可考虑加用溃疡下UGFS以加速愈合。
  • 溃疡下UGFS可能作为静脉性腿溃疡管理的补充治疗选项。
  • 临床决策时应结合本研究样本量小于原计划的局限性进行个体化评估。

局限性

  • 研究样本量小于原计划。
  • 研究为非盲设计。
  • 结果需在较小样本背景下解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate the efficacy of adding sub-ulcer ultrasound guided foam sclerotherapy (UGFS) to the treatment of venous leg ulcers (VLUs). METHODS: This was a multicentre, non-blinded, parallel group, randomised controlled trial. The FINNULCER trial recruited patients with VLU from four vascular surgery units in Finland. Eligible participants were randomly allocated either to the study group, which received immediate sub-ulcer UGFS in addition to conventional treatment, or to the control group, which received conventional treatment only. Conventional treatment included scheduled endothermal ablation for refluxing truncal veins, UGFS for tributaries, compression therapy, and local ulcer care. The recommended compression therapy was a class 2 (23 - 32 mmHg) thigh high compression stocking. The primary outcome was time to ulcer healing within 1 year of follow up. Secondary outcomes included quality of life questionnaires, treatment characteristics, and complications. RESULTS: Seventy-three patients were randomised (35 to the study group, 38 to the control group). During follow up, all ulcers healed in the study group, whereas four of 38 ulcers did not heal in the control group. The median time to ulcer healing was 55 days (95% confidence interval [CI] 42 - 68 days) in the study group and 91 days (95% CI 73 - 109 days) in the control group. In a Cox proportional hazards model adjusted for study site, ulcer healing was faster in the study group (hazard ratio 1.81, 95% CI 1.10 - 2.96; p = .019). Quality of life improved similarly in both groups. Overall complication rates were similar in both groups. CONCLUSION: Adding sub-ulcer UGFS to conventional VLU treatment shortened ulcer healing time without increasing the overall complication rate. These findings suggest that treatment of the sub-ulcer venous plexus may represent a useful addition to the management of VLUs, although the results should be interpreted in the context of a smaller study population than originally planned.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Pihlaja T, Pokela M, Ohtonen P, et al. Sub-ulcer Ultrasound Guided Foam Sclerotherapy for Venous Leg Ulcers: Results of the FINNULCER Randomised Controlled Trial. Eur J Vasc Endovasc Surg. 2026. PMID: 42392521. doi:10.1016/j.ejvs.2026.06.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。